BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Li P, Zhao W, Yang R, Chen S, Bai Y, Dun S, Chen X, Du Y, Wang Y, Zang W, Zhao G, Zhang G. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int 2015;15:48. [PMID: 26052251 DOI: 10.1186/s12935-015-0201-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Wang C, Lu X, Xu X, Shi T, Chen J. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs. Front Oncol 2022;12:927524. [DOI: 10.3389/fonc.2022.927524] [Reference Citation Analysis]
2 Zheng W, Guo J, Lu X, Qiao Y, Liu D, Pan S, Liang L, Liu C, Zhu H, Liu Z, Liu Z. cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1. Metabolism 2022;:155155. [PMID: 35093327 DOI: 10.1016/j.metabol.2022.155155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 2021. [PMID: 34907642 DOI: 10.1111/jcmm.17126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Sheykhhasan M, Ahmadyousefi Y, Seyedebrahimi R, Tanzadehpanah H, Manoochehri H, Dama P, Hosseini NF, Akbari M, Eslami Farsani M. DLX6-AS1: a putative lncRNA candidate in multiple human cancers. Expert Rev Mol Med 2021;23:e17. [PMID: 34823630 DOI: 10.1017/erm.2021.17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhao X, Wang J, Zhu R, Zhang J, Zhang Y. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Sci Rep 2021;11:21014. [PMID: 34697393 DOI: 10.1038/s41598-021-99555-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Zeng D, Hu Z, Yi Y, Valeria B, Shan G, Chen Z, Zhan C, Lin M, Lin Z, Wang Q. Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation. BMC Pulm Med 2021;21:316. [PMID: 34635074 DOI: 10.1186/s12890-021-01671-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Luo Y, Ge P, Wang M, Chen H, Liu J, Wei T, Jiang Y, Qu J, Chen H. Research progress of DLX6-AS1 in human cancers. Hum Cell 2021;34:1642-52. [PMID: 34508305 DOI: 10.1007/s13577-021-00613-0] [Reference Citation Analysis]
8 Wu C, Lin W, Fu F. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis. Transl Cancer Res 2021;10:3772-87. [PMID: 35116677 DOI: 10.21037/tcr-21-1240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yu X, Lin Q, Liu F, Yang F, Mao J, Chen X. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. Int J Immunopathol Pharmacol 2020;34:2058738420958947. [PMID: 32969763 DOI: 10.1177/2058738420958947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Cell Transplant 2020;29:963689720929983. [PMID: 32686982 DOI: 10.1177/0963689720929983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
11 Zhang Z, Yang L, Li Y, Wu Y, Li X, Wu X. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma. Open Med (Wars) 2021;16:660-71. [PMID: 33981850 DOI: 10.1515/med-2021-0276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Baldini F, Calderoni M, Vergani L, Modesto P, Florio T, Pagano A. An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma. Int J Mol Sci 2021;22:4234. [PMID: 33921816 DOI: 10.3390/ijms22084234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Balihodzic A, Barth DA, Prinz F, Pichler M. Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer. Cancers (Basel) 2021;13:977. [PMID: 33652661 DOI: 10.3390/cancers13050977] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
14 Cai Y, Hao M, Chang Y, Liu Y. LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1. Cancer Cell Int 2021;21:8. [PMID: 33407473 DOI: 10.1186/s12935-020-01657-2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Alizadeh A, Jebelli A, Baradaran B, Amini M, Oroojalian F, Hashemzaei M, Mokhtarzadeh A, Hamblin MR. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers. Gene 2021;769:145224. [PMID: 33059027 DOI: 10.1016/j.gene.2020.145224] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Bai L, Peng X, Sun R. Knockdown of circPRKCA Restrained Cell Growth, Migration, and Invasion of NSCLC Cells Both in vitro and in vivo via Regulating miR-330-5p/PDK1/AKT Pathway. Cancer Manag Res 2020;12:9125-37. [PMID: 33061606 DOI: 10.2147/CMAR.S258370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhao H, Xu Q. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region. J Cell Mol Med 2020;24:12572-84. [PMID: 32951317 DOI: 10.1111/jcmm.15810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
18 Hu Y, Sun H, Hu J, Zhang X. LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p. Cancer Manag Res 2020;12:7451-63. [PMID: 32904436 DOI: 10.2147/CMAR.S252521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang H, Niu X, Jiang H, Mao F, Zhong B, Jiang X, Fu G. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Aging (Albany NY) 2020;12:16021-34. [PMID: 32756011 DOI: 10.18632/aging.103374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kong WQ, Liang JJ, Du J, Ye ZX, Gao P, Liang YL. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating miR-26a/EZH2 Axis. Cancer Biother Radiopharm 2020. [PMID: 32379493 DOI: 10.1089/cbr.2020.3589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
21 Li C, Wang S, Yang C. Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p. Life Sci 2020;252:117657. [PMID: 32289431 DOI: 10.1016/j.lfs.2020.117657] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
22 Qian Y, Song W, Wu X, Hou G, Wang H, Hang X, Xia T. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290. Dig Dis Sci 2021;66:460-73. [PMID: 32239379 DOI: 10.1007/s10620-020-06223-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
23 Gupta C, Su J, Zhan M, Stass SA, Jiang F. Sputum long non-coding RNA biomarkers for diagnosis of lung cancer. Cancer Biomark 2019;26:219-27. [PMID: 31450489 DOI: 10.3233/CBM-190161] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
24 Ji W, Diao YL, Qiu YR, Ge J, Cao XC, Yu Y. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death Dis 2020;11:16. [PMID: 31907362 DOI: 10.1038/s41419-019-2213-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 46] [Article Influence: 11.5] [Reference Citation Analysis]
25 Al-Eitan LN, Alghamdi MA, Tarkhan AH, Al-Qarqaz FA. Genome-Wide Tiling Array Analysis of HPV-Induced Warts Reveals Aberrant Methylation of Protein-Coding and Non-Coding Regions. Genes (Basel) 2019;11:E34. [PMID: 31892232 DOI: 10.3390/genes11010034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yao Y, Zhang T, Qi L, Liu R, Liu G, Wang X, Li J, Li J, Sun C. Competitive Endogenous RNA Network Construction and Comparison of Lung Squamous Cell Carcinoma in Smokers and Nonsmokers. Dis Markers 2019;2019:5292787. [PMID: 31885738 DOI: 10.1155/2019/5292787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
27 Yang B, Jia L, Ren H, Jin C, Ren Q, Zhang H, Hu D, Zhang H, Hu L, Xie T. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Mol Genet Genomic Med 2020;8:e1017. [PMID: 31782911 DOI: 10.1002/mgg3.1017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
28 Guo J, Chen Z, Jiang H, Yu Z, Peng J, Xie J, Li Z, Wu W, Cheng Z, Xiao K. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway. Cancer Cell Int 2019;19:312. [PMID: 31787849 DOI: 10.1186/s12935-019-1010-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
29 Zhao P, Guan H, Dai Z, Ma Y, Zhao Y, Liu D. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis. Eur J Pharmacol 2019;865:172778. [PMID: 31705901 DOI: 10.1016/j.ejphar.2019.172778] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
30 Wang M, Sun X, Wang H, Xin Y, Jiao W. Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies. Transl Cancer Res 2019;8:2636-53. [PMID: 35117021 DOI: 10.21037/tcr.2019.10.22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Wu Q, Ma J, Meng W, Hui P. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1. Cancer Biol Ther 2020;21:17-25. [PMID: 31591939 DOI: 10.1080/15384047.2019.1647050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
32 Zhang X, Guo H, Bao Y, Yu H, Xie D, Wang X. Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer. Oncol Lett 2019;18:5197-204. [PMID: 31612030 DOI: 10.3892/ol.2019.10892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
33 Liang Y, Zhang CD, Zhang C, Dai DQ. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer. Gastric Cancer 2020;23:212-27. [PMID: 31463827 DOI: 10.1007/s10120-019-01002-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 9.7] [Reference Citation Analysis]
34 Jiang L, Li Z, Wang R. Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review). Int J Oncol 2019;55:585-96. [PMID: 31364742 DOI: 10.3892/ijo.2019.4850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wu DM, Zheng ZH, Zhang YB, Fan SH, Zhang ZF, Wang YJ, Zheng YL, Lu J. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells. J Exp Clin Cancer Res 2019;38:237. [PMID: 31171015 DOI: 10.1186/s13046-019-1239-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
36 Sun W, Zhang L, Yan R, Yang Y, Meng X. LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis. Onco Targets Ther 2019;12:3945-54. [PMID: 31190891 DOI: 10.2147/OTT.S196865] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
37 Yang J, Ye Z, Mei D, Gu H, Zhang J. Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer. Cancer Manag Res 2019;11:4209-21. [PMID: 31118816 DOI: 10.2147/CMAR.S194453] [Cited by in Crossref: 29] [Cited by in F6Publishing: 42] [Article Influence: 9.7] [Reference Citation Analysis]
38 Fu X, Tian Y, Kuang W, Wen S, Guo W. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells. Exp Ther Med 2019;17:4715-22. [PMID: 31105791 DOI: 10.3892/etm.2019.7521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tian W, Jiang C, Huang Z, Xu D, Zheng S. Comprehensive analysis of dysregulated lncRNAs, miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma. Gene 2019;696:206-18. [PMID: 30802540 DOI: 10.1016/j.gene.2019.02.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
40 Bach DH, Lee SK. Long noncoding RNAs in cancer cells. Cancer Lett. 2018;419:152-166. [PMID: 29414303 DOI: 10.1016/j.canlet.2018.01.053] [Cited by in Crossref: 89] [Cited by in F6Publishing: 103] [Article Influence: 29.7] [Reference Citation Analysis]
41 Cong Z, Diao Y, Xu Y, Li X, Jiang Z, Shao C, Ji S, Shen Y, De W, Qiang Y. Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis 2019;10:84. [PMID: 30692511 DOI: 10.1038/s41419-019-1361-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 76] [Article Influence: 18.3] [Reference Citation Analysis]
42 Guo Q, Sun H, Zheng K, Yin S, Niu J. Long non-coding RNA DLX6-AS1/miR-141-3p axis regulates osteosarcoma proliferation, migration and invasion through regulating Rab10. RSC Adv 2019;9:33823-33. [DOI: 10.1039/c9ra05180e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Huang Y, Ni R, Wang J, Liu Y. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Biomed Pharmacother 2019;109:1851-9. [PMID: 30551440 DOI: 10.1016/j.biopha.2018.09.151] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
44 Zhang RM, Tang T, Yu HM, Yao XD. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling. Biochem Biophys Res Commun 2018;507:260-6. [PMID: 30442366 DOI: 10.1016/j.bbrc.2018.11.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
45 Zhang Y, Li H, Zhang W, Che Y, Bai W, Huang G. LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer. Mol Med Rep 2018;18:5579-93. [PMID: 30365077 DOI: 10.3892/mmr.2018.9567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
46 An Y, Chen XM, Yang Y, Mo F, Jiang Y, Sun DL, Cai HH. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer. Cancer Cell Int 2018;18:143. [PMID: 30250401 DOI: 10.1186/s12935-018-0643-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
47 Lin Y, Leng Q, Zhan M, Jiang F. A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer. Transl Oncol 2018;11:1225-31. [PMID: 30098474 DOI: 10.1016/j.tranon.2018.07.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
48 Tan Y, Xiao D, Xu Y, Wang C. Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis. Exp Cell Res 2018;370:718-24. [PMID: 30055134 DOI: 10.1016/j.yexcr.2018.07.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
49 Wei MM, Zhou YC, Wen ZS, Zhou B, Huang YC, Wang GZ, Zhao XC, Pan HL, Qu LW, Zhang J, Zhang C, Cheng X, Zhou GB. Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis. Oncotarget 2016;7:59556-71. [PMID: 27322209 DOI: 10.18632/oncotarget.10006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
50 Li F, Huang C, Li Q, Wu X. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer. Med Sci Monit 2018;24:37-49. [PMID: 29295970 DOI: 10.12659/msm.905410] [Cited by in Crossref: 23] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
51 Zhang L, He X, Jin T, Gang L, Jin Z. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed Pharmacother 2017;96:884-91. [PMID: 29145165 DOI: 10.1016/j.biopha.2017.10.056] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
52 Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X, Liu Z. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis. Cell Cycle 2017;16:2212-9. [PMID: 28881158 DOI: 10.1080/15384101.2017.1361072] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
53 Castillo J, Stueve TR, Marconett CN. Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications. Oncotarget 2017;8:81538-57. [PMID: 29113413 DOI: 10.18632/oncotarget.18432] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
54 Li CQ, Huang GW, Wu ZY, Xu YJ, Li XC, Xue YJ, Zhu Y, Zhao JM, Li M, Zhang J, Wu JY, Lei F, Wang QY, Li S, Zheng CP, Ai B, Tang ZD, Feng CC, Liao LD, Wang SH, Shen JH, Liu YJ, Bai XF, He JZ, Cao HH, Wu BL, Wang MR, Lin DC, Koeffler HP, Wang LD, Li X, Li EM, Xu LY. Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma. Oncogenesis 2017;6:e297. [PMID: 28194033 DOI: 10.1038/oncsis.2017.1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
55 Wei MM, Zhou GB. Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer. Genomics Proteomics Bioinformatics 2016;14:280-8. [PMID: 27397102 DOI: 10.1016/j.gpb.2016.03.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 11.2] [Reference Citation Analysis]
56 Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type: Epithelial-Myoepithelial ACC Subtyping. Cancer 2016;122:1513-22. [DOI: 10.1002/cncr.29959] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
57 Ricciuti B, Mencaroni C, Paglialunga L, Paciullo F, Crinò L, Chiari R, Metro G. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy. Med Oncol 2016;33:18. [PMID: 26786153 DOI: 10.1007/s12032-016-0731-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 102] [Article Influence: 12.3] [Reference Citation Analysis]
58 Xu YJ, Du Y, Fan Y. Long noncoding RNAs in lung cancer: what we know in 2015. Clin Transl Oncol 2016;18:660-5. [PMID: 26680632 DOI: 10.1007/s12094-015-1448-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]